By integrating a series of bioinformatics methods, our study identified 6 TLR-related genes (IFNAR2, RAC1, LBP, TLR2, MAPK10, CXCL9), which have the potential to serve as new indicators of melanoma progression and prognosis. Here, MAPK10 is linked to melanoma.